Charles Schwab Investment Management Inc Rigel Pharmaceuticals Inc Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$0.72 - $1.56 $86,824 - $188,120	-120,590 Reduced 13.95%	743,615 $1.08 Million
Q2 2023 Aug 09, 2023	SELL	$1.12 - $1.82 $2,363 - $3,840	-2,110 Reduced 0.24%	864,205 $1.11 Million
Q1 2023 May 11, 2023	BUY	$1.25 - $2.0 $82,022 - $131,236	65,618 Added 8.2%	866,315 $1.14 Million
Q4 2022 Feb 13, 2023	SELL	$0.67 - $11.9 $46,160 - $819,874	-68,897 Reduced 7.92%	800,697 $1.2 Million
Q3 2022 Nov 14, 2022	BUY	$1.1 - $12.2 $2,468 - $27,376	2,244 Added 0.26%	869,594 $1.03 Million
Q2 2022 Aug 15, 2022	SELL	$0.67 - $3.19 $2,239 - $10,664	-3,343 Reduced 0.38%	867,350 $981,000
Q1 2022 May 13, 2022	BUY	$2.22 - $3.45 $61,631 - $95,778	27,762 Added 3.29%	870,693 $2.6 Million
Q4 2021 Feb 11, 2022	BUY	$2.36 - $3.57 $21,376 - $32,337	9,058 Added 1.09%	842,931 $2.23 Million
Q3 2021 Nov 16, 2021	BUY	$3.5 - $4.5 $1.42 Million - $1.83 Million	406,561 Added 95.14%	833,873 $3.03 Million
Q2 2021 Aug 16, 2021	SELL	$3.09 - $4.54 $11,127 - $16,348	-3,601 Reduced 0.84%	427,312 $1.86 Million
Q1 2021 May 17, 2021	BUY	$3.35 - $4.93 $46,163 - $67,935	13,780 Added 3.3%	430,913 $1.47 Million
Q4 2020 Feb 16, 2021	BUY	$2.35 - $3.74 $39,531 - $62,914	16,822 Added 4.2%	417,133 $1.46 Million
Q3 2020 Nov 13, 2020	SELL	$1.78 - $4.13 $29,337 - $68,070	-16,482 Reduced 3.95%	400,311 $961,000
Q2 2020 Aug 14, 2020	BUY	$1.41 - $2.05 $19,301 - $28,062	13,689 Added 3.4%	416,793 $763,000
Q1 2020 May 15, 2020	SELL	$1.27 - $3.0 $176 - $417	-139 Reduced 0.03%	403,104 $629,000
Q2 2019 Aug 09, 2019	BUY	$2.02 - $2.61 $50,477 - $65,221	24,989 Added 6.61%	403,243 $1.05 Million
Q1 2019 May 14, 2019	BUY	$2.0 - $2.65 $22,046 - $29,210	11,023 Added 3.0%	378,254 $973,000
Q3 2018 Nov 13, 2018	BUY	$2.6 - $3.59 $29,720 - $41,037	11,431 Added 3.21%	367,231 $1.18 Million
Q2 2018 Aug 08, 2018	BUY	$2.83 - $4.11 $156,499 - $227,283	55,300 Added 18.4%	355,800 $1.01 Million
Q1 2018 May 07, 2018	BUY	$3.54 - $4.54 $4,602 - $5,902	1,300 Added 0.43%	300,500 $1.06 Million
Q4 2017 Jan 17, 2018	BUY	$3.23 - $4.3 $100,776 - $134,160	31,200 Added 11.64%	299,200 $1.16 Million
Q3 2017 Nov 13, 2017	BUY	$2.18 - $2.57 $584,240 - $688,760	268,000	268,000 $681,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account